0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Therapeutic BCG Vaccines Market Insights and Forecast to 2028
Published Date: February 2022
|
Report Code: QYRE-Auto-31B795
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Global Therapeutic BCG Vaccines Market Insights and Forecast to 2028

Global Therapeutic BCG Vaccines Market Insights and Forecast to 2028

Code: QYRE-Auto-31B795
Report
February 2022
Pages:92
QYResearch
Description
Table of Content
Tables & Figures
Market Analysis and Insights: Global Therapeutic BCG Vaccines Market

Due to the COVID-19 pandemic, the global Therapeutic BCG Vaccines market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, 0.5ml Package accounting for % of the Therapeutic BCG Vaccines global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Therapeutic BCG Vaccines market size is valued at US$ million in 2021, while the US and Europe Therapeutic BCG Vaccines are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Therapeutic BCG Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Therapeutic BCG Vaccines include Merck, Sanofi Pasteur (Sanofi), Japan BCG Lab, Serum Institute of India, Intervax and GSBPL, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Therapeutic BCG Vaccines Scope and Segment
Therapeutic BCG Vaccines market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Therapeutic BCG Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

0.5ml Package
1ml Package
2ml Package
Other

Segment by Application

Hospitals
Clinics
Others

BY COMPANY

Merck
Sanofi Pasteur (Sanofi)
Japan BCG Lab
Serum Institute of India
Intervax
GSBPL

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
1 Study Coverage
1.1 Therapeutic BCG Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Therapeutic BCG Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 0.5ml Package
1.2.3 1ml Package
1.2.4 2ml Package
1.2.5 Other
1.3 Market by Application
1.3.1 Global Therapeutic BCG Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Therapeutic BCG Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Therapeutic BCG Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Therapeutic BCG Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Therapeutic BCG Vaccines Sales by Region
2.4.1 Global Therapeutic BCG Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Therapeutic BCG Vaccines by Region (2023-2028)
2.5 Global Therapeutic BCG Vaccines Revenue by Region
2.5.1 Global Therapeutic BCG Vaccines Revenue by Region (2017-2022)
2.5.2 Global Therapeutic BCG Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Therapeutic BCG Vaccines Sales by Manufacturers
3.1.1 Global Top Therapeutic BCG Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Therapeutic BCG Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Therapeutic BCG Vaccines in 2021
3.2 Global Therapeutic BCG Vaccines Revenue by Manufacturers
3.2.1 Global Therapeutic BCG Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Therapeutic BCG Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Therapeutic BCG Vaccines Revenue in 2021
3.3 Global Therapeutic BCG Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Therapeutic BCG Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Therapeutic BCG Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Therapeutic BCG Vaccines Sales by Type
4.1.1 Global Therapeutic BCG Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Therapeutic BCG Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Therapeutic BCG Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Therapeutic BCG Vaccines Revenue by Type
4.2.1 Global Therapeutic BCG Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Therapeutic BCG Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Therapeutic BCG Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Therapeutic BCG Vaccines Price by Type
4.3.1 Global Therapeutic BCG Vaccines Price by Type (2017-2022)
4.3.2 Global Therapeutic BCG Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Therapeutic BCG Vaccines Sales by Application
5.1.1 Global Therapeutic BCG Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Therapeutic BCG Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Therapeutic BCG Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Therapeutic BCG Vaccines Revenue by Application
5.2.1 Global Therapeutic BCG Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Therapeutic BCG Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Therapeutic BCG Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Therapeutic BCG Vaccines Price by Application
5.3.1 Global Therapeutic BCG Vaccines Price by Application (2017-2022)
5.3.2 Global Therapeutic BCG Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Therapeutic BCG Vaccines Market Size by Type
6.1.1 North America Therapeutic BCG Vaccines Sales by Type (2017-2028)
6.1.2 North America Therapeutic BCG Vaccines Revenue by Type (2017-2028)
6.2 North America Therapeutic BCG Vaccines Market Size by Application
6.2.1 North America Therapeutic BCG Vaccines Sales by Application (2017-2028)
6.2.2 North America Therapeutic BCG Vaccines Revenue by Application (2017-2028)
6.3 North America Therapeutic BCG Vaccines Market Size by Country
6.3.1 North America Therapeutic BCG Vaccines Sales by Country (2017-2028)
6.3.2 North America Therapeutic BCG Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Therapeutic BCG Vaccines Market Size by Type
7.1.1 Europe Therapeutic BCG Vaccines Sales by Type (2017-2028)
7.1.2 Europe Therapeutic BCG Vaccines Revenue by Type (2017-2028)
7.2 Europe Therapeutic BCG Vaccines Market Size by Application
7.2.1 Europe Therapeutic BCG Vaccines Sales by Application (2017-2028)
7.2.2 Europe Therapeutic BCG Vaccines Revenue by Application (2017-2028)
7.3 Europe Therapeutic BCG Vaccines Market Size by Country
7.3.1 Europe Therapeutic BCG Vaccines Sales by Country (2017-2028)
7.3.2 Europe Therapeutic BCG Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Therapeutic BCG Vaccines Market Size by Type
8.1.1 Asia Pacific Therapeutic BCG Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Therapeutic BCG Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Therapeutic BCG Vaccines Market Size by Application
8.2.1 Asia Pacific Therapeutic BCG Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Therapeutic BCG Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Therapeutic BCG Vaccines Market Size by Region
8.3.1 Asia Pacific Therapeutic BCG Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Therapeutic BCG Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Therapeutic BCG Vaccines Market Size by Type
9.1.1 Latin America Therapeutic BCG Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Therapeutic BCG Vaccines Revenue by Type (2017-2028)
9.2 Latin America Therapeutic BCG Vaccines Market Size by Application
9.2.1 Latin America Therapeutic BCG Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Therapeutic BCG Vaccines Revenue by Application (2017-2028)
9.3 Latin America Therapeutic BCG Vaccines Market Size by Country
9.3.1 Latin America Therapeutic BCG Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Therapeutic BCG Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Therapeutic BCG Vaccines Market Size by Type
10.1.1 Middle East and Africa Therapeutic BCG Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Therapeutic BCG Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Therapeutic BCG Vaccines Market Size by Application
10.2.1 Middle East and Africa Therapeutic BCG Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Therapeutic BCG Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Therapeutic BCG Vaccines Market Size by Country
10.3.1 Middle East and Africa Therapeutic BCG Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Therapeutic BCG Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Overview
11.1.3 Merck Therapeutic BCG Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Merck Therapeutic BCG Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Sanofi Pasteur (Sanofi)
11.2.1 Sanofi Pasteur (Sanofi) Corporation Information
11.2.2 Sanofi Pasteur (Sanofi) Overview
11.2.3 Sanofi Pasteur (Sanofi) Therapeutic BCG Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Sanofi Pasteur (Sanofi) Therapeutic BCG Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sanofi Pasteur (Sanofi) Recent Developments
11.3 Japan BCG Lab
11.3.1 Japan BCG Lab Corporation Information
11.3.2 Japan BCG Lab Overview
11.3.3 Japan BCG Lab Therapeutic BCG Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Japan BCG Lab Therapeutic BCG Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Japan BCG Lab Recent Developments
11.4 Serum Institute of India
11.4.1 Serum Institute of India Corporation Information
11.4.2 Serum Institute of India Overview
11.4.3 Serum Institute of India Therapeutic BCG Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Serum Institute of India Therapeutic BCG Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Serum Institute of India Recent Developments
11.5 Intervax
11.5.1 Intervax Corporation Information
11.5.2 Intervax Overview
11.5.3 Intervax Therapeutic BCG Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Intervax Therapeutic BCG Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Intervax Recent Developments
11.6 GSBPL
11.6.1 GSBPL Corporation Information
11.6.2 GSBPL Overview
11.6.3 GSBPL Therapeutic BCG Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 GSBPL Therapeutic BCG Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 GSBPL Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Therapeutic BCG Vaccines Industry Chain Analysis
12.2 Therapeutic BCG Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Therapeutic BCG Vaccines Production Mode & Process
12.4 Therapeutic BCG Vaccines Sales and Marketing
12.4.1 Therapeutic BCG Vaccines Sales Channels
12.4.2 Therapeutic BCG Vaccines Distributors
12.5 Therapeutic BCG Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Therapeutic BCG Vaccines Industry Trends
13.2 Therapeutic BCG Vaccines Market Drivers
13.3 Therapeutic BCG Vaccines Market Challenges
13.4 Therapeutic BCG Vaccines Market Restraints
14 Key Findings in The Global Therapeutic BCG Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Therapeutic BCG Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of 0.5ml Package
    Table 3. Major Manufacturers of 1ml Package
    Table 4. Major Manufacturers of 2ml Package
    Table 5. Major Manufacturers of Other
    Table 6. Global Therapeutic BCG Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Therapeutic BCG Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Therapeutic BCG Vaccines Sales by Region (2017-2022) & (Kg)
    Table 9. Global Therapeutic BCG Vaccines Sales Market Share by Region (2017-2022)
    Table 10. Global Therapeutic BCG Vaccines Sales by Region (2023-2028) & (Kg)
    Table 11. Global Therapeutic BCG Vaccines Sales Market Share by Region (2023-2028)
    Table 12. Global Therapeutic BCG Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Therapeutic BCG Vaccines Revenue Market Share by Region (2017-2022)
    Table 14. Global Therapeutic BCG Vaccines Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Therapeutic BCG Vaccines Revenue Market Share by Region (2023-2028)
    Table 16. Global Therapeutic BCG Vaccines Sales by Manufacturers (2017-2022) & (Kg)
    Table 17. Global Therapeutic BCG Vaccines Sales Share by Manufacturers (2017-2022)
    Table 18. Global Therapeutic BCG Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Therapeutic BCG Vaccines Revenue Share by Manufacturers (2017-2022)
    Table 20. Therapeutic BCG Vaccines Price by Manufacturers (2017-2022) &(USD/g)
    Table 21. Global Therapeutic BCG Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Therapeutic BCG Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic BCG Vaccines as of 2021)
    Table 23. Therapeutic BCG Vaccines Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Therapeutic BCG Vaccines Product Offered
    Table 25. Date of Manufacturers Enter into Therapeutic BCG Vaccines Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Therapeutic BCG Vaccines Sales by Type (2017-2022) & (Kg)
    Table 28. Global Therapeutic BCG Vaccines Sales by Type (2023-2028) & (Kg)
    Table 29. Global Therapeutic BCG Vaccines Sales Share by Type (2017-2022)
    Table 30. Global Therapeutic BCG Vaccines Sales Share by Type (2023-2028)
    Table 31. Global Therapeutic BCG Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Therapeutic BCG Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Therapeutic BCG Vaccines Revenue Share by Type (2017-2022)
    Table 34. Global Therapeutic BCG Vaccines Revenue Share by Type (2023-2028)
    Table 35. Therapeutic BCG Vaccines Price by Type (2017-2022) & (USD/g)
    Table 36. Global Therapeutic BCG Vaccines Price Forecast by Type (2023-2028) & (USD/g)
    Table 37. Global Therapeutic BCG Vaccines Sales by Application (2017-2022) & (Kg)
    Table 38. Global Therapeutic BCG Vaccines Sales by Application (2023-2028) & (Kg)
    Table 39. Global Therapeutic BCG Vaccines Sales Share by Application (2017-2022)
    Table 40. Global Therapeutic BCG Vaccines Sales Share by Application (2023-2028)
    Table 41. Global Therapeutic BCG Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Therapeutic BCG Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Therapeutic BCG Vaccines Revenue Share by Application (2017-2022)
    Table 44. Global Therapeutic BCG Vaccines Revenue Share by Application (2023-2028)
    Table 45. Therapeutic BCG Vaccines Price by Application (2017-2022) & (USD/g)
    Table 46. Global Therapeutic BCG Vaccines Price Forecast by Application (2023-2028) & (USD/g)
    Table 47. North America Therapeutic BCG Vaccines Sales by Type (2017-2022) & (Kg)
    Table 48. North America Therapeutic BCG Vaccines Sales by Type (2023-2028) & (Kg)
    Table 49. North America Therapeutic BCG Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Therapeutic BCG Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Therapeutic BCG Vaccines Sales by Application (2017-2022) & (Kg)
    Table 52. North America Therapeutic BCG Vaccines Sales by Application (2023-2028) & (Kg)
    Table 53. North America Therapeutic BCG Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Therapeutic BCG Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Therapeutic BCG Vaccines Sales by Country (2017-2022) & (Kg)
    Table 56. North America Therapeutic BCG Vaccines Sales by Country (2023-2028) & (Kg)
    Table 57. North America Therapeutic BCG Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Therapeutic BCG Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Therapeutic BCG Vaccines Sales by Type (2017-2022) & (Kg)
    Table 60. Europe Therapeutic BCG Vaccines Sales by Type (2023-2028) & (Kg)
    Table 61. Europe Therapeutic BCG Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Therapeutic BCG Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Therapeutic BCG Vaccines Sales by Application (2017-2022) & (Kg)
    Table 64. Europe Therapeutic BCG Vaccines Sales by Application (2023-2028) & (Kg)
    Table 65. Europe Therapeutic BCG Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Therapeutic BCG Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Therapeutic BCG Vaccines Sales by Country (2017-2022) & (Kg)
    Table 68. Europe Therapeutic BCG Vaccines Sales by Country (2023-2028) & (Kg)
    Table 69. Europe Therapeutic BCG Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Therapeutic BCG Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Therapeutic BCG Vaccines Sales by Type (2017-2022) & (Kg)
    Table 72. Asia Pacific Therapeutic BCG Vaccines Sales by Type (2023-2028) & (Kg)
    Table 73. Asia Pacific Therapeutic BCG Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Therapeutic BCG Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Therapeutic BCG Vaccines Sales by Application (2017-2022) & (Kg)
    Table 76. Asia Pacific Therapeutic BCG Vaccines Sales by Application (2023-2028) & (Kg)
    Table 77. Asia Pacific Therapeutic BCG Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Therapeutic BCG Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Therapeutic BCG Vaccines Sales by Region (2017-2022) & (Kg)
    Table 80. Asia Pacific Therapeutic BCG Vaccines Sales by Region (2023-2028) & (Kg)
    Table 81. Asia Pacific Therapeutic BCG Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Therapeutic BCG Vaccines Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Therapeutic BCG Vaccines Sales by Type (2017-2022) & (Kg)
    Table 84. Latin America Therapeutic BCG Vaccines Sales by Type (2023-2028) & (Kg)
    Table 85. Latin America Therapeutic BCG Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Therapeutic BCG Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Therapeutic BCG Vaccines Sales by Application (2017-2022) & (Kg)
    Table 88. Latin America Therapeutic BCG Vaccines Sales by Application (2023-2028) & (Kg)
    Table 89. Latin America Therapeutic BCG Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Therapeutic BCG Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Therapeutic BCG Vaccines Sales by Country (2017-2022) & (Kg)
    Table 92. Latin America Therapeutic BCG Vaccines Sales by Country (2023-2028) & (Kg)
    Table 93. Latin America Therapeutic BCG Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Therapeutic BCG Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Therapeutic BCG Vaccines Sales by Type (2017-2022) & (Kg)
    Table 96. Middle East and Africa Therapeutic BCG Vaccines Sales by Type (2023-2028) & (Kg)
    Table 97. Middle East and Africa Therapeutic BCG Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Therapeutic BCG Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Therapeutic BCG Vaccines Sales by Application (2017-2022) & (Kg)
    Table 100. Middle East and Africa Therapeutic BCG Vaccines Sales by Application (2023-2028) & (Kg)
    Table 101. Middle East and Africa Therapeutic BCG Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Therapeutic BCG Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Therapeutic BCG Vaccines Sales by Country (2017-2022) & (Kg)
    Table 104. Middle East and Africa Therapeutic BCG Vaccines Sales by Country (2023-2028) & (Kg)
    Table 105. Middle East and Africa Therapeutic BCG Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Therapeutic BCG Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 107. Merck Corporation Information
    Table 108. Merck Description and Major Businesses
    Table 109. Merck Therapeutic BCG Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
    Table 110. Merck Therapeutic BCG Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Merck Recent Developments
    Table 112. Sanofi Pasteur (Sanofi) Corporation Information
    Table 113. Sanofi Pasteur (Sanofi) Description and Major Businesses
    Table 114. Sanofi Pasteur (Sanofi) Therapeutic BCG Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
    Table 115. Sanofi Pasteur (Sanofi) Therapeutic BCG Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Sanofi Pasteur (Sanofi) Recent Developments
    Table 117. Japan BCG Lab Corporation Information
    Table 118. Japan BCG Lab Description and Major Businesses
    Table 119. Japan BCG Lab Therapeutic BCG Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
    Table 120. Japan BCG Lab Therapeutic BCG Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Japan BCG Lab Recent Developments
    Table 122. Serum Institute of India Corporation Information
    Table 123. Serum Institute of India Description and Major Businesses
    Table 124. Serum Institute of India Therapeutic BCG Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
    Table 125. Serum Institute of India Therapeutic BCG Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Serum Institute of India Recent Developments
    Table 127. Intervax Corporation Information
    Table 128. Intervax Description and Major Businesses
    Table 129. Intervax Therapeutic BCG Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
    Table 130. Intervax Therapeutic BCG Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Intervax Recent Developments
    Table 132. GSBPL Corporation Information
    Table 133. GSBPL Description and Major Businesses
    Table 134. GSBPL Therapeutic BCG Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
    Table 135. GSBPL Therapeutic BCG Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. GSBPL Recent Developments
    Table 137. Key Raw Materials Lists
    Table 138. Raw Materials Key Suppliers Lists
    Table 139. Therapeutic BCG Vaccines Distributors List
    Table 140. Therapeutic BCG Vaccines Customers List
    Table 141. Therapeutic BCG Vaccines Market Trends
    Table 142. Therapeutic BCG Vaccines Market Drivers
    Table 143. Therapeutic BCG Vaccines Market Challenges
    Table 144. Therapeutic BCG Vaccines Market Restraints
    Table 145. Research Programs/Design for This Report
    Table 146. Key Data Information from Secondary Sources
    Table 147. Key Data Information from Primary Sources
List of Figures
    Figure 1. Therapeutic BCG Vaccines Product Picture
    Figure 3. Global Therapeutic BCG Vaccines Market Share by Type in 2021 & 2028
    Figure 3. 0.5ml Package Product Picture
    Figure 4. 1ml Package Product Picture
    Figure 5. 2ml Package Product Picture
    Figure 6. Other Product Picture
    Figure 7. Global Therapeutic BCG Vaccines Market Share by Application in 2021 & 2028
    Figure 8. Hospitals
    Figure 9. Clinics
    Figure 10. Others
    Figure 11. Therapeutic BCG Vaccines Report Years Considered
    Figure 12. Global Therapeutic BCG Vaccines Sales 2017-2028 (Kg)
    Figure 13. Global Therapeutic BCG Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Therapeutic BCG Vaccines Revenue 2017-2028 (US$ Million)
    Figure 15. Global Therapeutic BCG Vaccines Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 16. Global Therapeutic BCG Vaccines Sales Market Share by Region (2017-2022)
    Figure 17. Global Therapeutic BCG Vaccines Sales Market Share by Region (2023-2028)
    Figure 18. North America Therapeutic BCG Vaccines Sales YoY (2017-2028) & (Kg)
    Figure 19. North America Therapeutic BCG Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Europe Therapeutic BCG Vaccines Sales YoY (2017-2028) & (Kg)
    Figure 21. Europe Therapeutic BCG Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Asia-Pacific Therapeutic BCG Vaccines Sales YoY (2017-2028) & (Kg)
    Figure 23. Asia-Pacific Therapeutic BCG Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Latin America Therapeutic BCG Vaccines Sales YoY (2017-2028) & (Kg)
    Figure 25. Latin America Therapeutic BCG Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Middle East & Africa Therapeutic BCG Vaccines Sales YoY (2017-2028) & (Kg)
    Figure 27. Middle East & Africa Therapeutic BCG Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. The Therapeutic BCG Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 29. The Top 5 and 10 Largest Manufacturers of Therapeutic BCG Vaccines in the World: Market Share by Therapeutic BCG Vaccines Revenue in 2021
    Figure 30. Global Therapeutic BCG Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 31. Global Therapeutic BCG Vaccines Sales Market Share by Type (2017-2028)
    Figure 32. Global Therapeutic BCG Vaccines Revenue Market Share by Type (2017-2028)
    Figure 33. Global Therapeutic BCG Vaccines Sales Market Share by Application (2017-2028)
    Figure 34. Global Therapeutic BCG Vaccines Revenue Market Share by Application (2017-2028)
    Figure 35. North America Therapeutic BCG Vaccines Sales Market Share by Type (2017-2028)
    Figure 36. North America Therapeutic BCG Vaccines Revenue Market Share by Type (2017-2028)
    Figure 37. North America Therapeutic BCG Vaccines Sales Market Share by Application (2017-2028)
    Figure 38. North America Therapeutic BCG Vaccines Revenue Market Share by Application (2017-2028)
    Figure 39. North America Therapeutic BCG Vaccines Sales Share by Country (2017-2028)
    Figure 40. North America Therapeutic BCG Vaccines Revenue Share by Country (2017-2028)
    Figure 41. U.S. Therapeutic BCG Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 42. Canada Therapeutic BCG Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 43. Europe Therapeutic BCG Vaccines Sales Market Share by Type (2017-2028)
    Figure 44. Europe Therapeutic BCG Vaccines Revenue Market Share by Type (2017-2028)
    Figure 45. Europe Therapeutic BCG Vaccines Sales Market Share by Application (2017-2028)
    Figure 46. Europe Therapeutic BCG Vaccines Revenue Market Share by Application (2017-2028)
    Figure 47. Europe Therapeutic BCG Vaccines Sales Share by Country (2017-2028)
    Figure 48. Europe Therapeutic BCG Vaccines Revenue Share by Country (2017-2028)
    Figure 49. Germany Therapeutic BCG Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 50. France Therapeutic BCG Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 51. U.K. Therapeutic BCG Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 52. Italy Therapeutic BCG Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 53. Russia Therapeutic BCG Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 54. Asia Pacific Therapeutic BCG Vaccines Sales Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Therapeutic BCG Vaccines Revenue Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Therapeutic BCG Vaccines Sales Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Therapeutic BCG Vaccines Revenue Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Therapeutic BCG Vaccines Sales Share by Region (2017-2028)
    Figure 59. Asia Pacific Therapeutic BCG Vaccines Revenue Share by Region (2017-2028)
    Figure 60. China Therapeutic BCG Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 61. Japan Therapeutic BCG Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 62. South Korea Therapeutic BCG Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 63. India Therapeutic BCG Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 64. Australia Therapeutic BCG Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 65. Taiwan Therapeutic BCG Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 66. Indonesia Therapeutic BCG Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 67. Thailand Therapeutic BCG Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 68. Malaysia Therapeutic BCG Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 69. Philippines Therapeutic BCG Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 70. Latin America Therapeutic BCG Vaccines Sales Market Share by Type (2017-2028)
    Figure 71. Latin America Therapeutic BCG Vaccines Revenue Market Share by Type (2017-2028)
    Figure 72. Latin America Therapeutic BCG Vaccines Sales Market Share by Application (2017-2028)
    Figure 73. Latin America Therapeutic BCG Vaccines Revenue Market Share by Application (2017-2028)
    Figure 74. Latin America Therapeutic BCG Vaccines Sales Share by Country (2017-2028)
    Figure 75. Latin America Therapeutic BCG Vaccines Revenue Share by Country (2017-2028)
    Figure 76. Mexico Therapeutic BCG Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 77. Brazil Therapeutic BCG Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 78. Argentina Therapeutic BCG Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 79. Middle East and Africa Therapeutic BCG Vaccines Sales Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Therapeutic BCG Vaccines Revenue Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Therapeutic BCG Vaccines Sales Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Therapeutic BCG Vaccines Revenue Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Therapeutic BCG Vaccines Sales Share by Country (2017-2028)
    Figure 84. Middle East and Africa Therapeutic BCG Vaccines Revenue Share by Country (2017-2028)
    Figure 85. Turkey Therapeutic BCG Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 86. Saudi Arabia Therapeutic BCG Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 87. U.A.E Therapeutic BCG Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 88. Therapeutic BCG Vaccines Value Chain
    Figure 89. Therapeutic BCG Vaccines Production Process
    Figure 90. Channels of Distribution
    Figure 91. Distributors Profiles
    Figure 92. Bottom-up and Top-down Approaches for This Report
    Figure 93. Data Triangulation
    Figure 94. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user(purchaser of the report) to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Strategic Venue Partners
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Dengue Testing Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-26K6048
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Ebola Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-20L6129
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Cytomegalovirus Infection Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-4F6384
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global IVD Infectious Diseases Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-16N6009
Mon Apr 15 00:00:00 UTC 2024

Add to Cart